Radioimmunoassay and Biomarkers Core
Director: Muredach Reilly, MB BChTechnical Director: Heather Collins, Ph.D.
615 Clinincal Research Building (CRB)
The assay service has proven essential for current research in the DERC and Penn community. The core used to focus mainly on rat and human insulin, glucagon and C-peptide to a diverse, high-volume and cost-effective service. Over 50 different diabetes and endocrinology-related markers can be assayed.
In conjunction with the General Clinical Research Center (GCRC), we are now offering multiple analyte (multiplex) services. As part of a collaborative initiative, Dr. Collins initiated and established Luminex IS100 multiplex ELISA services. This system uses cell-sorting technology to measure multiple proteins simultaneously. This technology will be of great use for investigators studying transgenic mice, where sample volumes are low. In addition, the multiplex platform allows for screening of human cohorts in disease research particularly of small volume in repeated sampling protocols.
For the complete list of assays click here.
The objectives of the Radioimmunoassay and Biomarker Core includes:
- delivery of new services to existing and new investigators
- development of informatics infrastructure for efficient delivery of service
- engage proactively in outreach to the DERC/PENN research community to enhance efficiency, cost-sharing and increase users of Biomarker Core services.
Given the nature of the DERC Biomarker Core services (high-throughput, increasing need for expensive technology and informatics, potential for redundancy across other University NIH-sponsored cores), we have proactively engaged in collaborative and cost-sharing initiatives with the GCRC core laboratory. This has involved
(1) when appropriate encouragement of DERC and GCRC investigators to join both centers;
(2) reduction in overlap and redundancy as well as increased use of DERC specific services for investigators in both centers (e.g., DERC insulin and endocrine assay services for GCRC investigators),
(3) collaboration and cost sharing in establishing multiplex services, and
(4) cost-sharing purchase of STATLIA software for use on DERC gamma counters and Luminex platform.